
Sign up to save your podcasts
Or


CEO Frédéric Legros walks us through the science and explains why he believes ARTHEx has a unique approach compared to others we have seen in the field. The company raised an $87M series B in September.
By BiotechTV4.3
66 ratings
CEO Frédéric Legros walks us through the science and explains why he believes ARTHEx has a unique approach compared to others we have seen in the field. The company raised an $87M series B in September.

3,376 Listeners

421 Listeners

1,650 Listeners

947 Listeners

124 Listeners

321 Listeners

211 Listeners

6,443 Listeners

62 Listeners

10,020 Listeners

86 Listeners

34 Listeners

21 Listeners

0 Listeners

4 Listeners

3 Listeners

5 Listeners

37 Listeners